This company has been marked as potentially delisted and may not be actively trading. NASDAQ:APEN Apollo Endosurgery (APEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Apollo Endosurgery Stock (NASDAQ:APEN) 30 days 90 days 365 days Advanced Chart Get Apollo Endosurgery alerts:Sign Up Key Stats Today's Range N/A50-Day Range$9.87▼$10.0052-Week Range N/AVolume1.66 million shsAverage Volume1.43 million shsMarket Capitalization$579.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX. Read More Receive APEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollo Endosurgery and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APEN Stock News HeadlinesApollo Endosurgery Stock Price HistoryJune 4, 2025 | investing.comWeight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and MoreOctober 15, 2024 | globenewswire.comBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.September 10 at 2:00 AM | Banyan Hill Publishing (Ad)Apollo Pipes Ltd 531761February 1, 2024 | morningstar.comMAstronaut Frank Borman, commander of the first Apollo mission to the moon, dead at 95November 12, 2023 | nypost.comNApollo astronaut Ken Mattingly, who helped save the crew of Apollo 13, has diedNovember 5, 2023 | cnn.comGastric Band and Gastric Balloon Market to Witness Growth Acceleration | Apollo Endosurgery, Cousin Surgery, Spatz FGIA IncMay 10, 2023 | marketwatch.comApollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsApril 1, 2023 | finance.yahoo.comSee More Headlines APEN Stock Analysis - Frequently Asked Questions How were Apollo Endosurgery's earnings last quarter? Apollo Endosurgery, Inc. (NASDAQ:APEN) issued its quarterly earnings results on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.05. The biotechnology company had revenue of $16.35 million for the quarter, compared to analyst estimates of $16.20 million. Apollo Endosurgery had a negative trailing twelve-month return on equity of 89.48% and a negative net margin of 51.84%. Read the conference call transcript. What other stocks do shareholders of Apollo Endosurgery own? Based on aggregate information from My MarketBeat watchlists, some other companies that Apollo Endosurgery investors own include Pfizer (PFE), Novavax (NVAX), NVIDIA (NVDA), Ocugen (OCGN), Canopy Growth (CGC), Inovio Pharmaceuticals (INO) and Meta Platforms (META). Company Calendar Last Earnings10/31/2021Today9/10/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:APEN CIK1251769 Webwww.apolloendo.com Phone(512) 279-5100Fax858-678-0900Employees202Year Founded2005Profitability EPS (Trailing Twelve Months)($1.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$39.84 million Net Margins-51.84% Pretax Margin-51.08% Return on Equity-89.48% Return on Assets-33.76% Debt Debt-to-Equity Ratio1.04 Current Ratio2.35 Quick Ratio1.89 Sales & Book Value Annual Sales$76.86 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.69 per share Price / BookN/AMiscellaneous Outstanding Shares57,972,000Free Float47,943,000Market Cap$579.72 million OptionableNot Optionable Beta2.31 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:APEN) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollo Endosurgery, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollo Endosurgery With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.